Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD

By James M. Paik, P. Golabi, Youssef Younossi, Alita Mishra, Z. Younossi. Hepatology, 2020

634 citations recorded by the source corpus.

Chronic hepatitis B virus (HBV), hepatitis C virus (HCV), nonalcoholic fatty liver disease (NAFLD), and alcohol‐associated liver disease (ALD) are main causes of chronic liver disease. We assessed the global incidence, mortality, and disability‐adjusted life‐years (DALYs) related to chronic liver disease (primary liver cancer [LC] and cirrhosis).

Subfields: Epidemiology, Hepatology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/aedbae75b9f8771f80d0708e3bb8ff3fd11ddb65

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Z. Younossi
2. L. Henry
3. P. Golabi
4. James M. Paik

In Hepatology

1. Z. Younossi

In Pathology and Forensic Medicine

1. L. Henry
2. Z. Younossi

Citations in the corpus

• The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review (2023, methodology): “[11] Recent data from the GBD related to mortality and disability adjusted years suggest that the burden of NAFLD is experienced across the globe and this burden is rapidly increasing.[12,13] To estimate the epidemiologic burden of NAFLD across the world, we used the most current data to determine t”